ALXO ALX Oncology Holdings Inc. - Common Stock
NASDAQ · Biotechnology · Lihat di SEC EDGAR ↗ 10-K/10-Q Agu 6, 2026
$1,17
· % dari rentang 52 mgg
· di atas terendah
· ke tinggi
$0,86rendah 52m
$2,65tinggi 52m
Kapitalisasi Pasar (MRQ)
$162M
P/E
-1.6
EPS
$-1.90
lencana Anda
Rentang 52M
$1–$3
Peringkat Analis
BUY
Target Harga
$5
P/E
-1.6
ROE
-225.0%
Margin Laba Bersih
·
Strip lencana Anda kosong — sematkan metrik di mana saja di halaman ini.
ALXO Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$1.17
Kapitalisasi Pasar (MRQ)
$162M
P/E
-1.6
EPS
$-1.90
ROE
-225.0%
D/E Utang/Ekuitas (MRQ)
0.1
Rentang 52M
$1–$3
ALXO Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
rentang
batang
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan·2018-12-31 → 2022-12-31
EPS$-1.902020-12-31 → 2025-12-31
Arus Kas Bebas$-84M2020-12-31 → 2025-12-31
Margin bersih·2020-12-31 → 2020-12-31
Valuasi & Rasio
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
| Metrik | Tren 5 Tahun | ALXO | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| P/E | -1.6rata-rata 5T ≈-3.9 | ≈-3.9 | · | · | |
| P/S | 43.3rata-rata 5T ≈79.8 | ≈79.8 | 81.4 | Terlalu mahal | |
| P/B (MRQ) | 1.2rata-rata 5T ≈2.2 | ≈2.2 | 2.1 | Nilai wajar | |
| EV / EBITDA (TTM) | -0.4rata-rata 5T ≈-1.3 | ≈-1.3 | · | · | |
| Harga / FCF (TTM) | -2.3rata-rata 5T ≈-5.0 | ≈-5.0 | · | · | |
| Harga / Arus Kas (TTM) | -2.3rata-rata 5T ≈-5.0 | ≈-5.0 | · | · | |
| EV / Revenue (EV / Pendapatan) | 33.9rata-rata 5T ≈50.7 | ≈50.7 | · | · | |
| EV / FCF (TTM) | -0.5rata-rata 5T ≈-1.7 | ≈-1.7 | · | · | |
| Price / Tangible Book (Harga / Nilai Buku Berwujud) | 6.2rata-rata 5T ≈2.2 | ≈2.2 | · | · |
Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
| Metrik | Tren 5 Tahun | ALXO | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| ROA | -98.3%rata-rata 5T ≈-56.5% | ≈-56.5% | -26.2% | Lemah | |
| ROE | -225.0%rata-rata 5T ≈-97.9% | ≈-97.9% | -32.4% | Lemah | |
| ROIC | -291.1%rata-rata 5T ≈-120.3% | ≈-120.3% | -48.7% | Lemah |
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
| Metrik | Tren 5 Tahun | ALXO | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Utang / Ekuitas (MRQ) | 0.1rata-rata 5T ≈0.1 | ≈0.1 | · | · | |
| Rasio Lancar (MRQ) | 9.7rata-rata 5T ≈9.6 | ≈9.6 | 9.6 | Sejajar | |
| Quick Ratio (Rasio Cepat) | 1.8rata-rata 5T ≈9.4 | ≈9.4 | 9.2 | Sejajar | |
| Utang Jangka Panjang / Ekuitas (MRQ) | 0.1rata-rata 5T ≈0.1 | ≈0.1 | · | · | |
| Interest Coverage (Cakupan Bunga) | -64.9rata-rata 5T ≈-85.4 | ≈-85.4 | -20.1 | Likuiditas rendah |
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Belum ada data untuk grup rasio ini
Data fundamental belum cukup untuk menghitung grup rasio ini.
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
Belum ada data untuk grup rasio ini
Data fundamental belum cukup untuk menghitung grup rasio ini.
nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
3.0%
Laporan Berikutnya
Nov 05, 2026
| Periode | Laporan | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|---|
| 30 Juni 2026 | Agu 10, 2026 | $-0.12 | $-0.15 | 17.9% |
| 31 Maret 2026 | $-0.15 | $-0.20 | 26.2% | |
| 31 Des. 2025 | $-0.37 | $-0.37 | -0.08% | |
| 30 Sep. 2025 | $-0.41 | $-0.37 | -9.6% | |
| 30 Juni 2025 | $-0.43 | $-0.46 | 6.3% | |
| 31 Maret 2025 | $-0.58 | $-0.47 | -22.5% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | $0 | $0 | $1M | $5M | |
| R&D Expense | $77M | $116M | $142M | $98M | $60M | $29M | $16M | |
| SG&A Expense | $24M | $26M | $28M | $29M | $23M | $15M | $3M | |
| Operating Expenses | $104M | $142M | $170M | $127M | $84M | $45M | $24M | |
| Operating Income | $-104M | $-142M | $-170M | $-127M | $-84M | $-44M | $-19M | |
| Interest Expense | $2M | $2M | $2M | $238.0K | $13.0K | · | · | |
| Interest Income | $4M | $9M | $11M | $4M | $91.0K | · | · | |
| Other Non-op | $-36.0K | $-20.0K | $389.0K | $-22.0K | $-7.0K | $-1M | $-5.0K | |
| Pretax Income | $-102M | $-135M | $-161M | $-123M | $-83M | $-45M | $-19M | |
| Income Tax | $0 | $0 | $0 | $64.0K | $-21.0K | $241.0K | $34.0K | |
| Net Income | $-102M | $-135M | $-161M | $-123M | $-83M | $-46M | $-19M | |
| EPS (Basic) | $-1.90 | $-2.58 | $-3.74 | $-3.03 | $-2.07 | $-2.76 | · | |
| EPS (Diluted) | $-1.90 | $-2.58 | $-3.74 | $-3.03 | $-2.07 | $-2.76 | · | |
| Shares (Basic) | 53,658,399 | 52,174,904 | 42,987,767 | 40,699,612 | 40,308,050 | 18,485,343 | 3,076,461 | |
| Shares (Diluted) | 53,658,399 | 52,174,904 | 42,987,767 | 40,699,612 | 40,308,050 | 18,485,343 | · | |
| EBITDA | $-103M | $-142M | $-169M | $-127M | $-84M | $-43M | · |
Neraca
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $16M | $18M | $22M | $49M | $364M | $434M | $9M | |
| Short-term Investments | $28M | $110M | $160M | $217M | · | · | · | |
| Prepaid Expense | $6M | $7M | $6M | $5M | $3M | $2M | $256.0K | |
| Other Current Assets | $20.0K | $27.0K | $439.0K | · | · | · | · | |
| Current Assets | $51M | $134M | $189M | $271M | $367M | $436M | $10M | |
| PP&E (Net) | $1M | $3M | $4M | $4M | $897.0K | $52.0K | $860.0K | |
| PP&E (Gross) | $3M | $5M | $5M | $4M | $960.0K | $77.0K | $2M | |
| Accum. Depreciation | $2M | $2M | $1M | $403.0K | $63.0K | $25.0K | $1M | |
| Other Non-current Assets | $4M | $7M | $15M | $15M | $12M | $10.0K | $7.0K | |
| Total Assets | $59M | $148M | $243M | $306M | $380M | $436M | $11M | |
| Accounts Payable | $5M | $4M | $9M | $8M | $4M | $4.0K | $4M | |
| Current Liabilities | $25M | $18M | $36M | $28M | $15M | $6M | $5M | |
| Capital Leases | $3M | $3M | $4M | $5M | $2M | · | · | |
| Other Non-current Liabilities | $4M | $6M | $7M | $5M | $2M | $5.0K | $547.0K | |
| Total Liabilities | $33M | $34M | $53M | $43M | $17M | $6M | $11M | |
| Long-term Debt | $10M | $11M | $11M | $11M | · | · | · | |
| Total Debt | $10M | $10M | $10M | $9M | · | · | · | |
| Common Stock | $54.0K | $53.0K | $50.0K | $41.0K | $41.0K | $40.0K | $3.0K | |
| Retained Earnings | $-723M | $-621M | $-486M | $-325M | $-202M | $-119M | $-73M | |
| AOCI | $28.0K | $275.0K | $256.0K | $-845.0K | · | · | · | |
| Stockholders' Equity | $26M | $114M | $190M | $263M | $363M | $430M | $-71M | |
| Liabilities + Equity | $59M | $148M | $243M | $306M | $380M | $436M | $11M | |
| Shares Outstanding | 54,388,022 | 53,052,912 | 49,951,989 | 40,861,386 | 40,587,067 | 39,844,522 | 3,166,946 |
Arus Kas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $706.0K | $872.0K | $836.0K | $342.0K | $51.0K | $202.0K | $429.0K | |
| Stock-based Comp | $13M | $27M | $26M | $24M | $14M | $5M | $297.0K | |
| Deferred Tax | $0 | $0 | $0 | · | · | · | · | |
| Other Non-cash | $4M | $-15M | $3M | $10M | $1M | $2M | · | |
| Operating Cash Flow | $-84M | $-122M | $-130M | $-89M | $-68M | $-38M | $-14M | |
| CapEx | $212.0K | $447.0K | $1M | $1M | $666.0K | $31.0K | $353.0K | |
| Investing Cash Flow | $83M | $86M | $45M | $-235M | $-5M | $610.0K | $-353.0K | |
| Stock Issued | $2M | $30M | · | · | · | $368M | · | |
| Net Stock Activity | $2M | $30M | · | · | · | $368M | · | |
| Financing Cash Flow | $362.0K | $31M | $59M | $10M | $2M | $463M | $15M | |
| Free Cash Flow | $-84M | $-122M | $-132M | $-91M | $-69M | $-38M | · | |
| Levered FCF | $-86M | · | · | · | · | · | · |
Profitabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | -3694.0% | · | |
| Net Margin | · | · | · | · | · | -3869.7% | · | |
| Pretax Margin | · | · | · | · | · | -3849.3% | · | |
| EBITDA Margin | · | · | · | · | · | -3676.9% | · | |
| ROA | -98.3% | -69.1% | -58.6% | -36.0% | -20.4% | -20.5% | · | |
| ROE | -225.0% | -107.7% | -89.7% | -44.9% | -22.3% | -13.4% | · | |
| ROIC | -291.1% | · | · | -46.7% | -23.0% | -10.2% | · |
Likuiditas & Solvabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.1 | 7.3 | 5.2 | 9.6 | 24.0 | 70.3 | · | |
| Quick Ratio | 1.8 | 6.9 | 5.1 | 9.4 | 23.8 | 70.0 | · | |
| Debt / Equity | 0.4 | 0.1 | 0.1 | 0.0 | · | · | · | |
| LT Debt / Equity | 0.2 | 0.1 | 0.1 | 0.0 | · | · | · | |
| Interest Coverage | -64.9 | -82.4 | -108.8 | · | · | · | · |
Efisiensi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.0 | · | 0.0 | · |
Per Saham
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.48 | $2.14 | $3.80 | $6.45 | $8.94 | $10.79 | · | |
| Revenue / Share | · | · | · | $0.00 | · | · | · | |
| Cash Flow / Share | $-1.57 | $-2.34 | $-3.03 | $-2.19 | · | · | · | |
| Cash / Share | $0.30 | $0.33 | $0.45 | $1.19 | $8.96 | $10.90 | · | |
| EPS (TTM) | $-1.90 | $-2.58 | $-3.74 | $-3.03 | $-2.07 | $-2.76 | · |
Valuasi (TTM)
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4M | $4M | $4M | $0 | $0 | $1M | · | |
| Net Income TTM | $-102M | $-135M | $-161M | $-123M | $-83M | $-46M | · | |
| Market Cap | $61M | $89M | $744M | $461M | $872M | $3.43B | · | |
| Enterprise Value | $26M | $-29M | $571M | $204M | · | · | · | |
| P/E | -0.6 | -0.6 | -4.0 | -3.7 | -10.4 | -31.2 | · | |
| P/S | 16.5 | 23.7 | 199.2 | · | · | 2905.8 | · | |
| P/B | 2.4 | 0.8 | 3.9 | 1.7 | 2.4 | 8.0 | · | |
| P / Tangible Book | 2.4 | 0.8 | 3.9 | 1.7 | 2.4 | 8.0 | · | |
| P / Cash Flow | -0.7 | -0.7 | -5.7 | -5.2 | -12.8 | -89.7 | · | |
| P / FCF | -0.7 | -0.7 | -5.7 | -5.1 | -12.7 | -89.6 | · | |
| EV / EBITDA | -0.3 | 0.2 | -3.4 | -1.6 | · | · | · | |
| EV / FCF | -0.3 | 0.2 | -4.3 | -2.2 | · | · | · | |
| EV / Revenue | 7.1 | -7.8 | 152.9 | · | · | · | · | |
| Earnings Yield | -168.1% | -154.5% | -25.1% | -26.9% | -9.6% | -3.2% | · |
Laporan Laba Rugi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $13M | $14M | $18M | $17M | $18M | $24M | $24M | $26M | $35M | $32M | $46M | $29M | $25M | $29M | $27M | $17M | |
| SG&A Expense | $5M | $5M | $5M | $5M | $5M | $8M | $7M | $6M | $7M | $6M | $8M | $7M | $7M | $7M | $7M | $8M | |
| Operating Expenses | $18M | $19M | $23M | $23M | $27M | $32M | $31M | $33M | $42M | $38M | $53M | $37M | $32M | $37M | $34M | $25M | |
| Operating Income | $-18M | $-19M | $-23M | $-23M | $-27M | $-32M | $-31M | $-33M | $-42M | $-38M | $-53M | $-37M | $-32M | $-37M | $-34M | $-25M | |
| Interest Expense | $285.0K | $331.0K | $383.0K | $408.0K | $405.0K | $406.0K | $427.0K | $446.0K | $429.0K | $427.0K | $391.0K | $372.0K | $387.0K | $2.0K | $2.0K | $3.0K | |
| Interest Income | $2M | $1M | $573.0K | $802.0K | $1M | $1M | $2M | $2M | $3M | $3M | $3M | $3M | $2M | $1M | $876.0K | $225.0K | |
| Other Non-op | $-257.0K | $188.0K | $-17.0K | $-6.0K | $-2.0K | $-11.0K | $-1.0K | $3.0K | $-8.0K | $-14.0K | $-1.0K | $324.0K | $95.0K | $-7.0K | $-5.0K | $-8.0K | |
| Net Income | $-18M | $-18M | $-23M | $-22M | $-26M | $-31M | $-29M | $-31M | $-39M | $-36M | $-51M | $-34M | $-30M | $-35M | $-33M | $-25M | |
| EPS (Basic) | $-0.13 | $-0.17 | $-0.42 | $-0.41 | $-0.49 | $-0.58 | $-0.53 | $-0.58 | $-0.76 | $-0.71 | $-1.24 | $-0.84 | $-0.74 | $-0.87 | $-0.81 | $-0.60 | |
| EPS (Diluted) | $-0.13 | $-0.17 | $-0.42 | $-0.41 | $-0.49 | $-0.58 | $-0.53 | $-0.58 | $-0.76 | $-0.71 | $-1.24 | $-0.84 | $-0.74 | $-0.87 | $-0.81 | $-0.60 | |
| Shares (Basic) | 135,639,684 | 104,573,657 | · | 53,577,066 | 53,445,631 | 53,359,338 | · | 52,693,878 | 51,831,157 | 50,120,758 | 41,147,938 | 40,875,457 | 40,862,513 | 40,747,026 | 40,687,751 | 40,616,302 | |
| Shares (Diluted) | 135,639,684 | 104,573,657 | · | 53,577,066 | 53,445,631 | 53,359,338 | · | 52,693,878 | 51,831,157 | 50,120,758 | 41,147,938 | 40,875,457 | 40,862,513 | 40,747,026 | 40,687,751 | 40,616,302 | |
| EBITDA | $-18M | $-19M | · | $-23M | $-27M | $-32M | · | $-33M | $-42M | $-38M | $-53M | $-37M | $-32M | $-37M | $-34M | $-25M |
Neraca
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $23M | $32M | $16M | $23M | $19M | $21M | $18M | $16M | $16M | $14M | $20M | $38M | $63M | $49M | $66M | $159M | |
| Short-term Investments | $116M | $108M | $28M | $37M | $60M | $77M | $110M | $132M | $141M | $143M | $170M | $175M | $165M | $236M | $247M | $158M | |
| Prepaid Expense | $5M | $5M | $6M | $6M | $6M | $5M | $7M | $7M | $12M | $10M | $9M | $7M | $5M | $6M | $3M | $5M | |
| Other Current Assets | $542.0K | $25.0K | $20.0K | · | $4.0K | · | $27.0K | $1M | $315.0K | · | · | · | · | · | · | · | |
| Current Assets | $143M | $146M | $51M | $67M | $85M | $103M | $134M | $156M | $169M | $168M | $199M | $220M | $233M | $291M | $317M | $322M | |
| PP&E (Net) | $166.0K | $1M | $1M | $1M | $1M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $2M | $2M | $1M | |
| PP&E (Gross) | $1M | $3M | $3M | $3M | $3M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $3M | $2M | $1M | |
| Accum. Depreciation | $938.0K | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $823.0K | $616.0K | $300.0K | $205.0K | $121.0K | |
| Other Non-current Assets | $2M | $3M | $4M | $9M | $4M | $7M | $7M | $13M | $13M | $14M | $11M | $11M | $13M | $16M | $17M | $16M | |
| Total Assets | $161M | $178M | $59M | $83M | $95M | $121M | $148M | $186M | $215M | $213M | $220M | $246M | $278M | $318M | $346M | $364M | |
| Accounts Payable | $3M | $4M | $5M | $7M | $5M | $4M | $4M | $8M | $8M | $6M | $13M | $4M | $10M | $6M | $9M | $5M | |
| Current Liabilities | $15M | $20M | $25M | $28M | $19M | $19M | $18M | $32M | $38M | $32M | $35M | $18M | $22M | $25M | $24M | $15M | |
| Capital Leases | $0 | $2M | $3M | $3M | $3M | $3M | · | $4M | $4M | $4M | $5M | $5M | $5M | $5M | $6M | $5M | |
| Other Non-current Liabilities | $152.0K | $4M | $4M | $4M | $5M | $6M | $6M | $7M | $7M | $7M | $7M | $6M | $6M | $5M | $6M | $5M | |
| Total Liabilities | $25M | $27M | $33M | $38M | $31M | $33M | $34M | $49M | $55M | $48M | $51M | $33M | $38M | $31M | $30M | $20M | |
| Long-term Debt | $10M | $9M | $10M | $11M | $11M | $11M | $10M | $11M | $11M | $11M | $11M | $11M | $11M | · | · | · | |
| Total Debt | $10M | $9M | · | $10M | $10M | $10M | · | $10M | $10M | $10M | $10M | $10M | $9M | · | · | · | |
| Common Stock | $138.0K | $135.0K | $54.0K | $54.0K | $54.0K | $53.0K | $53.0K | $53.0K | $52.0K | $50.0K | $41.0K | $41.0K | $41.0K | $41.0K | $41.0K | $41.0K | |
| Retained Earnings | $-759M | $-741M | $-723M | $-700M | $-678M | $-652M | $-621M | $-592M | $-561M | $-522M | $-441M | $-390M | $-356M | $-295M | $-259M | $-227M | |
| AOCI | $-224.0K | $-245.0K | $28.0K | $43.0K | $36.0K | $118.0K | $275.0K | $563.0K | $-73.0K | $28.0K | $-226.0K | $-312.0K | $-88.0K | $-2M | $-1M | $-606.0K | |
| Stockholders' Equity | $136M | $151M | $26M | $45M | $64M | $88M | $114M | $137M | $159M | $164M | $169M | $213M | $240M | $287M | $316M | $344M | |
| Liabilities + Equity | $161M | $178M | $59M | $83M | $95M | $121M | $148M | $186M | $215M | $213M | $220M | $246M | $278M | $318M | $346M | $364M | |
| Shares Outstanding | 138,216,247 | 134,540,741 | 54,388,022 | 53,577,566 | 53,506,777 | 53,384,145 | 53,052,912 | 52,743,104 | 52,452,749 | 50,277,193 | 41,151,819 | 40,992,179 | 40,863,049 | 40,748,290 | 40,745,252 | 40,656,632 |
Arus Kas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $86.0K | $150.0K | $151.0K | $153.0K | $191.0K | $211.0K | $214.0K | $224.0K | $220.0K | $214.0K | $209.0K | $207.0K | $213.0K | $95.0K | $84.0K | $58.0K | |
| Stock-based Comp | $3M | $3M | $3M | $3M | $2M | $5M | $6M | $7M | $7M | $7M | $7M | $6M | $6M | $6M | $6M | $6M | |
| Other Non-cash | · | $-3M | · | · | · | $664.0K | · | · | · | $-10M | · | · | $-4M | · | · | $-2M | |
| Operating Cash Flow | $-16M | $-19M | $-19M | $-17M | $-23M | $-25M | $-32M | $-25M | $-27M | $-38M | $-31M | $-32M | $-28M | $-31M | $-17M | $-21M | |
| CapEx | $17.0K | $50.0K | $49.0K | $56.0K | $47.0K | $60.0K | $60.0K | $149.0K | $90.0K | $148.0K | $-1M | $2M | $690.0K | $192.0K | $257.0K | $589.0K | |
| Investing Cash Flow | $7M | $-105M | $11M | $21M | $22M | $28M | $33M | $26M | $907.0K | $26M | $13M | $6M | $42M | $14M | $-76M | $-184M | |
| Stock Issued | $0 | $11.0K | $1M | $0 | $0 | $372.0K | $359.0K | $75.0K | $26M | $3M | · | · | · | · | · | · | |
| Net Stock Activity | · | $11.0K | · | · | · | $372.0K | · | · | · | $3M | · | · | · | · | · | · | |
| Financing Cash Flow | $137.0K | $140M | $678.0K | $-159.0K | $-222.0K | $65.0K | $328.0K | $251.0K | $27M | $3M | $-111.0K | $343.0K | $-107.0K | $-136.0K | $422.0K | $80.0K | |
| Free Cash Flow | · | $-19M | · | · | · | $-25M | · | · | · | $-38M | · | · | $-29M | · | · | $-21M |
Profitabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -14.0% | -12.0% | · | -16.5% | -16.7% | -18.4% | · | -15.1% | -17.1% | -14.5% | -19.0% | -11.5% | -9.4% | -9.8% | -8.6% | -6.2% | |
| ROE | -17.9% | -15.0% | · | -24.4% | -23.2% | -24.4% | · | -20.1% | -21.2% | -17.6% | -22.4% | -12.9% | -10.3% | -10.5% | -9.1% | -6.4% |
Likuiditas & Solvabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.7 | 7.2 | · | 2.4 | 4.5 | 5.5 | · | 4.8 | 4.4 | 5.2 | 5.7 | 12.5 | 10.6 | 11.5 | 13.2 | 21.0 | |
| Quick Ratio | 9.4 | 7.0 | · | 2.2 | 4.2 | 5.2 | · | 4.6 | 4.1 | 4.9 | 5.4 | 12.1 | 10.4 | 11.3 | 13.1 | 20.7 | |
| Debt / Equity | 0.1 | 0.1 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | · | · | · | |
| LT Debt / Equity | 0.1 | 0.0 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | · | · | · | |
| Interest Coverage | -63.3 | -57.3 | · | -55.2 | -65.8 | -78.4 | · | -73.0 | -96.8 | -88.4 | -136.3 | -98.9 | -83.2 | · | · | · |
Per Saham
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.99 | $1.12 | · | $0.84 | $1.20 | $1.65 | · | $2.59 | $3.04 | $3.27 | $4.10 | $5.19 | $5.88 | $7.04 | $7.76 | $8.45 | |
| Cash Flow / Share | · | $-0.18 | · | · | · | $-0.46 | · | · | · | $-0.76 | · | · | $-0.68 | · | · | · | |
| Cash / Share | $0.16 | $0.24 | · | $0.44 | $0.36 | $0.39 | · | $0.31 | $0.30 | $0.28 | $0.48 | $0.93 | $1.55 | $1.20 | $1.63 | $3.91 | |
| EPS (TTM) | $-1.13 | $-1.49 | · | $-2.01 | $-2.18 | $-2.45 | · | $-2.97 | $-3.63 | $-3.71 | $-3.57 | $-3.20 | $-3.17 | $-2.98 | $-2.72 | $-2.31 |
Valuasi (TTM)
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1M | $1M | · | $1M | $1M | $1M | · | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Net Income TTM | $-81M | $-89M | · | $-108M | $-117M | $-130M | · | $-151M | $-171M | $-166M | $-146M | $-130M | $-129M | $-121M | $-110M | $-94M | |
| Market Cap | $286M | $270M | · | $98M | $22M | $33M | · | $96M | $316M | $561M | $198M | $308M | $185M | $390M | $330M | $687M | |
| Enterprise Value | $158M | $138M | · | $48M | $-47M | $-55M | · | $-43M | $169M | $413M | $17M | $105M | $-34M | · | · | · | |
| P/E | -1.8 | -1.3 | · | -0.9 | -0.2 | -0.3 | · | -0.6 | -1.7 | -3.0 | -1.3 | -2.3 | -1.4 | -3.2 | -3.0 | -7.3 | |
| P/S | 242.1 | 228.2 | · | 83.0 | 18.8 | 28.1 | · | 81.2 | 267.6 | 474.3 | 167.1 | 260.4 | 156.3 | 329.9 | 278.9 | 581.3 | |
| P/B | 2.1 | 1.8 | · | 2.2 | 0.3 | 0.4 | · | 0.7 | 2.0 | 3.4 | 1.2 | 1.4 | 0.8 | 1.4 | 1.0 | 2.0 | |
| P / Tangible Book | 2.1 | 1.8 | · | 2.2 | 0.3 | 0.4 | · | 0.7 | 2.0 | 3.4 | 1.2 | 1.4 | 0.8 | 1.4 | 1.0 | 2.0 | |
| P / Cash Flow | · | -14.5 | · | · | · | -1.3 | · | · | · | -14.8 | · | · | -6.6 | · | · | -33.2 | |
| EV / Revenue | 133.3 | 116.7 | · | 40.2 | -39.8 | -46.2 | · | -36.2 | 143.3 | 349.3 | 14.5 | 88.4 | -28.6 | · | · | · | |
| Earnings Yield | -54.6% | -74.3% | · | -109.8% | -525.3% | -393.3% | · | -163.2% | -60.2% | -33.3% | -74.4% | -42.6% | -70.1% | -31.1% | -33.6% | -13.7% |
Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Pendapatan | · | · | · | $0 | $0 |
| Laba Bersih | $-102M | $-135M | $-161M | $-123M | $-83M |
| EPS Dilusian | $-1.90 | $-2.58 | $-3.74 | $-3.03 | $-2.07 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Utang / Ekuitas | 0.4 | 0.1 | 0.1 | 0.0 | · |
| Rasio Lancar | 2.1 | 7.3 | 5.2 | 9.6 | 24.0 |
| Rasio Cepat | 1.8 | 6.9 | 5.1 | 9.4 | 23.8 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Arus Kas Bebas | $-84M | $-122M | $-132M | $-91M | $-69M |
Pemilik institusional (13F) 102 pengaju · $216.9M total · Per tanggal 30 Sep. 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Pemegang
102
Nilai yang dipegang
$216.9M
Posisi baru
38
Posisi yang keluar
11
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 38 (+14 vs Kuartal sebelumnya) | 11 (+1 vs Kuartal sebelumnya) | 28 (+10 vs Kuartal sebelumnya) | 11 (-2 vs Kuartal sebelumnya) | +16.7M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $26.934.527 | 13.011.849 | 12,42% | Saham |
| venBio Partners LLC | $26.671.201 | 12.884.638 | 12,30% | Saham |
| BlackRock, Inc. | $15.317.028 | 7.399.530 | 7,06% | Saham |
| Redmile Group, LLC | $15.302.483 | 7.392.504 | 7,06% | Saham |
| Blackstone Inc. | $13.648.634 | 6.593.543 | 6,29% | Saham |
| Driehaus Capital Management LLC | $12.472.247 | 6.025.240 | 5,75% | Saham |
| SILVERARC CAPITAL MANAGEMENT, LLC | $11.891.647 | 5.744.757 | 5,48% | Saham |
| TCG Crossover Management, LLC | $11.706.858 | 5.655.487 | 5,40% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $10.295.013 | 4.973.436 | 4,75% | Saham |
| Vivo Capital, LLC | $6.592.356 | 3.184.713 | 3,04% | Saham |
| MARSHALL WACE, LLP | $6.357.997 | 3.071.496 | 2,93% | Saham |
| 5AM Venture Management, LLC | $6.328.663 | 3.057.325 | 2,92% | Saham |
| Almitas Capital LLC | $6.082.552 | 2.938.431 | 2,80% | Saham |
| ORBIMED ADVISORS LLC | $5.933.150 | 2.866.256 | 2,74% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $5.771.224 | 2.787.809 | 2,66% | Saham |
| TWO SIGMA INVESTMENTS, LP | $4.508.824 | 2.178.176 | 2,08% | Saham |
| MILLENNIUM MANAGEMENT LLC | $3.195.240 | 1.543.594 | 1,47% | Saham |
| STATE STREET CORP | $3.102.733 | 1.498.905 | 1,43% | Saham |
| JPMORGAN CHASE & CO | $2.298.401 | 1.044.728 | 1,06% | Saham |
| NORTHERN TRUST CORP | $1.936.835 | 935.669 | 0,89% | Saham |
| VANGUARD GROUP INC | $1.842.962 | 1.630.940 | 0,85% | Saham |
| Ensign Peak Advisors, Inc | $1.677.315 | 810.297 | 0,77% | Saham |
| Nantahala Capital Management, LLC | $1.552.500 | 750.000 | 0,72% | Saham |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.550.904 | 749.229 | 0,72% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $1.539.026 | 743.491 | 0,71% | Saham |
| GOLDMAN SACHS GROUP INC | $1.536.625 | 742.331 | 0,71% | Saham |
| RENAISSANCE TECHNOLOGIES LLC | $1.249.860 | 603.797 | 0,58% | Saham |
| ADAR1 Capital Management, LLC | $1.104.676 | 533.660 | 0,51% | Saham |
| UBS Group AG | $958.292 | 462.943 | 0,44% | Saham |
| TWO SIGMA ADVISERS, LP | $802.752 | 710.400 | 0,37% | Saham |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $499.104 | 241.113 | 0,23% | Saham |
| Bank of New York Mellon Corp | $493.585 | 238.447 | 0,23% | Saham |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $467.969 | 226.072 | 0,22% | Saham |
| Atom Investors LP | $454.121 | 219.382 | 0,21% | Saham |
| IEQ CAPITAL, LLC | $363.041 | 175.382 | 0,17% | Saham |
| MORGAN STANLEY | $326.798 | 157.873 | 0,15% | Saham |
| Invesco Ltd. | $310.341 | 149.923 | 0,14% | Saham |
| Nuveen, LLC | $297.345 | 143.645 | 0,14% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $254.935 | 123.157 | 0,12% | Saham |
| RHUMBLINE ADVISERS | $223.350 | 107.902 | 0,10% | Saham |
| DEUTSCHE BANK AG\ | $222.376 | 107.428 | 0,10% | Saham |
| WELLS FARGO & COMPANY/MN | $206.847 | 99.926 | 0,10% | Saham |
| Verdad Advisers, LP | $170.154 | 82.200 | 0,08% | Saham |
| BANK OF AMERICA CORP /DE/ | $157.386 | 76.032 | 0,07% | Saham |
| Graham Capital Management, L.P. | $154.879 | 74.821 | 0,07% | Saham |
| XTX Topco Ltd | $144.190 | 69.657 | 0,07% | Saham |
| MetLife Investment Management, LLC | $134.465 | 64.959 | 0,06% | Saham |
| CITIGROUP INC | $104.815 | 50.635 | 0,05% | Saham |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $102.842 | 49.682 | 0,05% | Saham |
| Squarepoint Ops LLC | $97.019 | 46.869 | 0,04% | Saham |
Aktivis & pemilik 5%+ 5 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| GOODMAN COREY S, venBio Global Strategic Fund II L.P., venBio Global Strategic Fund, L.P., venBio Global Strategic GP II, L.P., venBio Global Strategic GP II, Ltd., venBio Global Strategic GP, L.P., venBio Global Strategic GP, Ltd. | 16 Okt. 2026 | 9,99% | Amandemen | Kampanye dewan | SEC |
| LSV Associates, LLC, Lightstone Ventures, L.P., Lightstone Ventures (A), L.P., LSV Associates II, LLC, Lightstone Ventures II, L.P., Lightstone Ventures II (A), L.P., Michael A Carusi, Jean George, Henry A. Plain Jr | 27 Mei 2026 | 2,20% | Amandemen | · | SEC |
| venBio Global Strategic Fund, L.P., venBio Global Strategic Fund II L.P., venBio Global Strategic GP, L.P., venBio Global Strategic GP II, L.P., venBio Global Strategic GP, Ltd., venBio Global Strategic GP II, Ltd., Adelman Robert J, GOODMAN COREY S ×2 pengajuan | 4 Feb. 2026 | 10,00% | Amandemen | · | SEC |
| Lightstone Ventures, L.P., Lightstone Ventures (A), L.P., LSV Associates, LLC, Lightstone Ventures II, L.P., Lightstone Ventures II (A), L.P., LSV Associates II, LLC, Michael A. Carusi, Jean M. George, Henry A. Plain, Jr. ×3 pengajuan | 14 Feb. 2024 | · | Pengajuan awal | · | SEC |
| Logos Global Management LP, Logos Global Management GP LLC, Arsani William, Graham Walmsley, Logos Opportunities Fund I LP, Logos Opportunities GP LLC, Logos GP LLC ×2 pengajuan | 15 Juni 2021 | · | Pengajuan awal | Investasi pasif | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Orang dalam perusahaan 19 orang dalam · 10 pejabat · 9 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Jason Lettmann | CHIEF EXECUTIVE OFFICER | 17 Agu 2026 S | 294.379 | 0 | 2 | $-31.019 |
| Harish Shantharam | Chief Financial Officer | 26 Jan. 2026 A | 75.000 | 0 | 0 | $0 |
| Peter S Garcia | CHIEF FINANCIAL OFFICER | 14 Agu 2024 F | 121.516 | 0 | 0 | $0 |
| Jaume Pons | PRESIDENT & CSO | 19 Feb. 2025 S | 579.388 | 0 | 0 | $0 |
| Shelly Pinto | SVP, FINANCE AND CAO | 17 Agu 2026 S | 87.828 | 0 | 5 | $-11.570 |
| Jeff E. Knight | Chief Dev & Operating Officer | 16 April 2026 A | · | 0 | 0 | $0 |
| Barbara Klencke | Chief Medical Officer | 16 April 2026 A | · | 0 | 0 | $0 |
| Sophia Randolph | CHIEF MEDICAL OFFICER | 14 Agu 2024 S | 325.711 | 0 | 0 | $0 |
| Nathan Caffo | Chief Business Officer | 21 Juli 2020 C | 11.254 | 0 | 0 | $0 |
| Steffen Pietzke | VP Fin & Chief Acct Officer | 21 Juli 2020 P | 3.000 | 0 | 0 | $0 |
| Daniel J. Curran | Direktur | 20 Jan. 2026 A | · | 0 | 0 | $0 |
| Alan B. Sandler | Direktur | 20 Jan. 2026 A | · | 0 | 0 | $0 |
| Rekha Hemrajani | Direktur | 20 Jan. 2026 A | 33.000 | 0 | 0 | $0 |
| Chris H Takimoto | Direktur | 20 Jan. 2026 A | · | 0 | 0 | $0 |
| Scott J. Garland | Direktur | 20 Jan. 2026 A | · | 0 | 0 | $0 |
| Itziar Canamasas | Direktur | 20 Juni 2023 A | · | 0 | 0 | $0 |
| Jack Nielsen | Direktur | 20 Juni 2023 A | · | 0 | 0 | $0 |
| Graham Walmsley | Direktur | 11 Juni 2021 A | 995.000 | 0 | 0 | $0 |
| Corey S Goodman | · | 2 Feb. 2026 P | 8.453.038 | 1 | 0 | $4.999.999 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Kepemilikan ETF Dimiliki oleh 12 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,35% | 59.488 SH | 23 Okt. 2026 | Harian |
| IWC · iShares Trust | 0,05% | 366.440 SH | 11 Sep. 2026 | Harian |
| IWO · iShares Trust | 0,01% | 1.013.254 SH | 11 Sep. 2026 | Harian |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 623.766 SH | 19 Agu 2026 | Harian |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 116.302 SH | 19 Agu 2026 | Harian |
| RSSL · Global X Funds | 0,01% | 51.536 NS | 31 Juli 2026 | N-PORT |
| IWM · iShares Trust | 0,01% | 2.551.278 SH | 11 Sep. 2026 | Harian |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,00% | 34.770 SH | 23 Okt. 2026 | Harian |
| DXUV · Dimensional ETF Trust | 0,00% | 1.343 NS | 31 Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 1.226.065 SH | 19 Agu 2026 | Harian |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 3.642.854 SH | 19 Agu 2026 | Harian |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 9.161 SH | 19 Agu 2026 | Harian |
ALXO Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
peringkat · 13 analis
BELI
Target median
$4.00
+241,9%
3 23,1%
Beli Kuat
8 61,5%
Beli
2 15,4%
Tahan
0 0,0%
Jual
0 0,0%
Jual Kuat
Target Harga 12 Bulan
5 analis · 2026-10-19Target rata-rata $4.60 +293,2%
← Di bawah semua target
Harga saat ini $1.17
Rendah$4.00
Rata-rata$4.60
Tinggi$6.00
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| ALXO | $61M | -0.6 | · | · | -225.0% | · |
| EVMN | $540M | -1.5 | 85.7% | -529.8% | -401.2% | · |
| TRDA | $394M | -3.0 | -87.9% | -565.5% | -41.9% | · |
| RNA | $10.91B | -14.5 | 72.1% | -3650.4% | -47.5% | · |
| IVVD | $697M | -8.2 | 110.5% | -98.2% | -36.9% | · |
| KRRO | $75M | -0.6 | 181.5% | -1834.5% | -140.8% | · |
| SION | $1.84B | -21.9 | · | · | -23.4% | · |
| AKBA | $427M | -80.5 | 47.5% | -2.3% | -17.3% | · |
| STRO | $99M | -0.5 | 65.2% | -186.5% | 232.2% | · |
| CHRS | $172M | 1.0 | 59.8% | 398.4% | 185.8% | · |
| UPB | $1.47B | -10.2 | 20.4% | -5026.0% | -38.3% | · |
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Sumber: SEC 10-Q diajukan Agu 6, 2026